ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.60
-0.14%
US Tech 100
19,409.60
1.26%
S&P 500
5,473.23
0.77%
US Dollar vs CAD
1.37398
0.19%
Bitcoin
65,703.77
-1.18%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. BriaCell Therapeutics Corporation (BCTXW)

  7. BriaCell Therapeutics Corporation (BCTXW) News

BCTXW

BriaCell Therapeutics (BCTXW)

BriaCell Therapeutics Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BCTXW
DateTimeSourceHeadlineSymbolCompany
06/14/20243:10PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BCTXWBriaCell Therapeutics Corporation
06/14/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXWBriaCell Therapeutics Corporation
06/03/20247:00AMGlobeNewswire Inc.BriaCell Presents Clinical Efficacy Data at ASCO 2024NASDAQ:BCTXWBriaCell Therapeutics Corporation
05/30/20247:00AMGlobeNewswire Inc.BriaCell Initiates Patient Enrollment in First-in-Human Study of Bria-OTS™ in Advanced Metastatic Breast CancerNASDAQ:BCTXWBriaCell Therapeutics Corporation
05/28/20247:00AMGlobeNewswire Inc.BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS™ First in Human StudyNASDAQ:BCTXWBriaCell Therapeutics Corporation
05/24/20247:58AMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BCTXWBriaCell Therapeutics Corporation
05/24/20247:00AMGlobeNewswire Inc.BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024NASDAQ:BCTXWBriaCell Therapeutics Corporation
05/20/20243:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCTXWBriaCell Therapeutics Corporation
05/17/20243:51PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXWBriaCell Therapeutics Corporation
05/17/20243:33PMGlobeNewswire Inc.BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct OfferingNASDAQ:BCTXWBriaCell Therapeutics Corporation
05/16/20244:10PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BCTXWBriaCell Therapeutics Corporation
05/15/20247:00AMGlobeNewswire Inc.BriaCell Therapeutics Announces Pricing of $5.0 Million Registered Direct OfferingNASDAQ:BCTXWBriaCell Therapeutics Corporation
04/24/20247:00AMGlobeNewswire Inc.BriaCell Announces Oral and Poster Presentations at ASCO 2024NASDAQ:BCTXWBriaCell Therapeutics Corporation
04/10/20247:00AMGlobeNewswire Inc.BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate CancerNASDAQ:BCTXWBriaCell Therapeutics Corporation
04/09/20247:00AMGlobeNewswire Inc.BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACRNASDAQ:BCTXWBriaCell Therapeutics Corporation
03/07/20247:00AMGlobeNewswire Inc.BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer ImmunotherapiesNASDAQ:BCTXWBriaCell Therapeutics Corporation
03/06/20247:00AMGlobeNewswire Inc.BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR ConferenceNASDAQ:BCTXWBriaCell Therapeutics Corporation
02/27/20247:00AMGlobeNewswire Inc.BriaCell Provides Update on Alleged Illegal Trading of Public SecuritiesNASDAQ:BCTXWBriaCell Therapeutics Corporation
02/07/20247:00AMGlobeNewswire Inc.BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder CaseNASDAQ:BCTXWBriaCell Therapeutics Corporation
02/06/20247:30AMGlobeNewswire Inc.Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP ManufacturingNASDAQ:BCTXWBriaCell Therapeutics Corporation
01/30/20249:48PMGlobeNewswire Inc.BriaCell Therapeutics Corp. Announces Results of Shareholder MeetingNASDAQ:BCTXWBriaCell Therapeutics Corporation
01/04/20247:45AMGlobeNewswire Inc.BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast CancerNASDAQ:BCTXWBriaCell Therapeutics Corporation
12/28/20237:55AMGlobeNewswire Inc.BriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer PatientsNASDAQ:BCTXWBriaCell Therapeutics Corporation
12/20/20237:40AMGlobeNewswire Inc.BriaCell Reports Unprecedented Preliminary Survival and Clinical Benefit in Antibody-Drug Conjugate (ADC) Refractory Patient SubsetNASDAQ:BCTXWBriaCell Therapeutics Corporation
12/06/20238:31AMGlobeNewswire Inc.BriaCell Highlights Outstanding Topline Survival and Clinical Benefit Data in Advanced Metastatic Breast Cancer at the 2023 SABCSNASDAQ:BCTXWBriaCell Therapeutics Corporation
12/06/20238:00AMGlobeNewswire Inc.BriaCell 2023 SABCS Posters Confirm Activation of Cancer-Fighting Immune Cells and Identify Potential Predictors of Clinical BenefitNASDAQ:BCTXWBriaCell Therapeutics Corporation
11/30/20236:00AMGlobeNewswire Inc.BriaCell Records New Responder with Remarkable Improvement of “Eye-Bulging” Metastatic TumorNASDAQ:BCTXWBriaCell Therapeutics Corporation
11/03/20237:31AMGlobeNewswire Inc.BriaCell Reports Unprecedented Anti-Tumor Activity of its Next Generation Personalized Breast and Prostate Cancer Immunotherapies in Tumor Models at the 2023 SITC Annual Meeting; FDA Greenlights Bria-OTS™ INDNASDAQ:BCTXWBriaCell Therapeutics Corporation
10/25/20238:15AMGlobeNewswire Inc.BriaCell Forms Medical Advisory Board of Distinguished Breast Cancer Specialists to Advance its Lead Oncology CandidateNASDAQ:BCTXWBriaCell Therapeutics Corporation
10/20/20238:15AMGlobeNewswire Inc.October is Breast Cancer Awareness Month – BriaCell is Leading the Fight with its Innovative TechnologyNASDAQ:BCTXWBriaCell Therapeutics Corporation
 Showing the most relevant articles for your search:NASDAQ:BCTXW

Your Recent History

NASDAQ
SRNE
Sorrento Therapeutics
NYSE
CRL
Charles River Laboratories
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved